| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 2.789 | 7.299 | 8.091 | 4.715 | 2.783 |
| Total Income - EUR | - | - | - | - | - | 2.789 | 7.316 | 8.091 | 4.715 | 2.783 |
| Total Expenses - EUR | - | - | - | - | - | 2.394 | 7.716 | 5.403 | 5.416 | 12.105 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 395 | -399 | 2.688 | -700 | -9.322 |
| Net Profit/Loss - EUR | - | - | - | - | - | 311 | -472 | 2.611 | -700 | -9.322 |
| Employees | - | - | - | - | - | 0 | 1 | 0 | 1 | 1 |
Check the financial reports for the company - Aproflu Mih Fmc S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 717 | 4.473 | 2.518 | 4.369 | 805 |
| Inventories | - | - | - | - | - | 650 | 2.424 | 1.434 | 1.463 | 38 |
| Receivables | - | - | - | - | - | 0 | 1.696 | 101 | 257 | 514 |
| Cash | - | - | - | - | - | 67 | 354 | 982 | 2.650 | 253 |
| Shareholders Funds | - | - | - | - | - | 352 | -128 | 2.483 | 1.775 | -7.556 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 364 | 4.601 | 34 | 2.594 | 8.362 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4721 - 4721" | |||||||||
| CAEN Financial Year |
4721
|
|||||||||
Comments - Aproflu Mih Fmc S.r.l.